Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2025-12-17 @ 2:57 AM
Study NCT ID:
NCT06250036
Status:
None
Last Update Posted:
2025-08-21 00:00:00
First Post:
2023-12-11 00:00:00
Brief Title:
Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer
Sponsor:
Organization:
Royal Marsden NHS Foundation Trust
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
50
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: